Filana Therapeutics (FLNA) Analyst & Key Data

Ratings

Updated Sep 12, 2026

Overall Rating

C+

DCF Score5.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score4.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$0.77

DCF Value+140.02%

$1.85

Potential upside vs current price

Current Stock Price

$0.77

DCF Value+140.02%

$1.85

Potential upside vs current price

Ratings

Updated Sep 12, 2026

Overall Rating

C+

DCF Score5.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score4.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$0.77

DCF Value+140.02%

$1.85

Potential upside vs current price

Current Stock Price

$0.77

DCF Value+140.02%

$1.85

Potential upside vs current price

Filana Therapeutics, Inc.